Differential regulation of FGF-1 and -2 mitogenic activity is related to their kinetics of binding to heparan sulfate in MDA-MB-231 human breast cancer cells.

The growth of the malignant human mammary MDA-MB-231 cells is stimulated by fibroblast growth factor-1 (FGF-1) but not by FGF-2. When these cells are cultured in the presence of chlorate, an inhibitor of heparan sulfate (HS) sulfation, their proliferation is stimulated by both FGF-1 and FGF-2. We analyzed the interactions of FGF-1 and FGF-2 with HS purified from the cell layer and the culture medium of control and chlorate-treated MDA-MB-231 cells. The HS from the cell layer bound FGF-1 with faster association kinetics than the HS from the culture medium, and so had a higher affinity for FGF-1. Chlorate treatment had no significant effect on the FGF-1 binding kinetics of the HS. In contrast to FGF-1, chlorate treatment of the cells significantly altered the FGF-2 binding kinetics. The HS from untreated cells possessed two binding sites for FGF-2, one with fast association kinetics (k(ass) 470,000 to 610,000 M(-1) s(-1)) and a high affinity (K(d) 46 to 70 nM) and one with slower association kinetics (k(ass) 74,000 to 100,000 M(-1) s(-1)) and a lower affinity (K(d) 290 to 400 nM). HS from chlorate-treated cells possessed just a single binding site for FGF-2 with fast association kinetics (k(ass) 270,000 to 290,000 M(-1) s(-1)) and a high affinity (K(d) 41 to 57 nM). These results show that there is a relationship between the binding kinetics of FGFs and their ability to stimulate cell growth.

[1]  H. Hondermarck,et al.  Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells. , 1996, Experimental cell research.

[2]  M. Salmivirta,et al.  Sequence analysis of heparan sulphate and heparin oligosaccharides. , 1999, The Biochemical journal.

[3]  V. Nurcombe,et al.  Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. , 1993, Science.

[4]  K. Yoshida,et al.  Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. , 1995, Journal of biochemistry.

[5]  P. Rudland,et al.  Immunocytochemical identification of basic fibroblast growth factor in the developing rat mammary gland: variations in location are dependent on glandular structure and differentiation. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  S. Leinster,et al.  Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. , 1994, British Journal of Cancer.

[7]  H. Hondermarck,et al.  Embryonic brain-derived heparan sulfate inhibits cellular membrane binding and biological activity of basic fibroblast growth factor. , 1992, Brain research. Developmental brain research.

[8]  P. Schuck,et al.  Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. , 1997, Annual review of biophysics and biomolecular structure.

[9]  B. Olwin,et al.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.

[10]  A. Yayon,et al.  Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. , 1994, The Journal of biological chemistry.

[11]  M. Ishihara.  Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. , 1994, Glycobiology.

[12]  Xiaochong Wu,et al.  Specificity for Fibroblast Growth Factors Determined by Heparan Sulfate in a Binary Complex with the Receptor Kinase* , 1999, The Journal of Biological Chemistry.

[13]  T. Irimura,et al.  Cancer cell heparanase activity associated with invasion and metastasis. , 1998, Advances in enzyme regulation.

[14]  M. Nugent,et al.  Endothelial proteoglycans inhibit bFGF binding and mitogenesis , 1997, Journal of cellular physiology.

[15]  C. Sanderson,et al.  Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases. , 1998, The Biochemical journal.

[16]  J. Smith,et al.  High-level production of human acidic fibroblast growth factor in E. coli cells: inhibition of DNA synthesis in rat mammary fibroblasts at high concentrations of growth factor. , 1990, Biochemical and biophysical research communications.

[17]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[18]  A. Baird,et al.  Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues , 1990, The Journal of cell biology.

[19]  S. Fox,et al.  Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes , 1997, Cancer research.

[20]  Masato Kato,et al.  Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 , 1998, Nature Medicine.

[21]  J. Turnbull,et al.  A strategy for rapid sequencing of heparan sulfate and heparin saccharides. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Jalkanen,et al.  Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans? , 1997, European journal of cell biology.

[23]  M. Kan,et al.  The heparan sulfate-fibroblast growth factor family: diversity of structure and function. , 1998, Progress in nucleic acid research and molecular biology.

[24]  P. Rudland,et al.  Hepatocyte growth factor/scatter factor has distinct classes of binding site in heparan sulfate from mammary cells. , 1998, Biochemistry.

[25]  M. Lyon,et al.  Highly Sensitive Sequencing of the Sulfated Domains of Heparan Sulfate* , 1999, The Journal of Biological Chemistry.

[26]  P. Rudland,et al.  Interaction of Heparan Sulfate from Mammary Cells with Acidic Fibroblast Growth Factor (FGF) and Basic FGF , 1998, The Journal of Biological Chemistry.

[27]  I. Vlodavsky,et al.  Substrate Specificity of Heparanases from Human Hepatoma and Platelets* , 1998, The Journal of Biological Chemistry.

[28]  R. Linhardt,et al.  Examination of the substrate specificity of heparin and heparan sulfate lyases. , 1990, Biochemistry.

[29]  J. Rosen,et al.  Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. , 1994, Molecular endocrinology.

[30]  B. Olwin,et al.  Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. , 1993, The Journal of biological chemistry.

[31]  J. Xu,et al.  An essential heparin-binding domain in the fibroblast growth factor receptor kinase. , 1993, Science.

[32]  D. Fernig,et al.  Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. , 1994, Progress in growth factor research.

[33]  R J Leatherbarrow,et al.  Kinetics of protein-protein interactions at the surface of an optical biosensor. , 1995, Analytical biochemistry.

[34]  J. Turnbull,et al.  Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. , 1994, The Journal of biological chemistry.

[35]  J. Smith,et al.  A rapid procedure for production of human basic fibroblast growth factor in Escherichia coli cells. , 1992, Biochimica et biophysica acta.

[36]  J. Turnbull,et al.  Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. , 1992, The Journal of biological chemistry.

[37]  J. Bonneterre,et al.  Basic fibroblast growth factor (bFGF): Mitogenic activity and binding sites in human breast cancer , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  P. Rudland,et al.  Synthesis of basic fibroblast growth factor upon differentiation of rat mammary epithelial to myoepithelial‐like cells in culture , 1990, Journal of cellular physiology.

[39]  M. Kiefer,et al.  Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor. , 1993, The Journal of biological chemistry.

[40]  L. Cousens,et al.  Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. , 1993, The Journal of biological chemistry.